Tue: Teva acquisition boosts market

Teva rose strongly on the acquisition of NuPathe, while Bezeq recorded the strongest gain on the Tel Aviv 25 Index.

The Tel Aviv Stock Exchange (TASE) rose today. The Tel Aviv 25 Index rose 0.35% to 1,332.87 points, the Tel Aviv 100 Index rose 0.56% to 1,229.36 points, and the BlueTech 50 Index rose 0.80% to 359.13 points. Turnover was NIS 1.29 billion.

The TASE rose today, in line with gains on European markets and at the opening on Wall Street.

In the foreign currency market, the Bank of Israel set the shekel-dollar representative exchange rate at NIS 3.498/$, up 0.14% on yesterday's rate, and set the shekel-euro representative exchange rate at NIS 4.733/€, up 0.02%.

In the bond market, long-term Shahar unlinked shekel government bonds and long term Galil CPI-linked government bonds rose fell. The corporate bond benchmark Tel-Bond 20 Index fell 0.05%.

In the stock market, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 1.7%, on the day's biggest turnover of NIS 116.1 million, after announcing the acquisition of NuPathe Inc. (Nasdaq: PATH). Bezeq Israeli Telecommunication Co. Ltd. (TASE: BEZQ) rose 2.2% for the biggest gain among Tel Aviv 25 shares, while mobile carrier Partner Communications Ltd. (Nasdaq: PTNR; TASE: PTNR) fell 2.4% for the biggest loss.

Migdal Insurance and Financial Holdings Ltd. (TASE: MGDL) fell 0.1%, after the Tel Aviv District Labor Court charged it with contempt of court.

Leviathan partners Delek Group Ltd. (TASE: DLEKG) rose 2.1% and Ratio Oil Exploration (1992) LP (TASE:RATI.L) rose 3.6%, despite a warning by Antitrust Authority director general David Gilo about possibly being declared a natural gas cartel.

In the life sciences, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; TASE: PLTR) corrected upwards 16.7%, after announcing positive results in a clinical trial. Small-cap BiondVax Pharmaceuticals Ltd. (TASE:BNDX) rose 6.1%, after announcing that its universal flu vaccine was a match for all six pandemic avail influenza strains and InsuLine Medical Ltd. (TASE: INSL) rose 5.1%, after announcing a distribution agreement in Belgium and the Netherlands.

Published by Globes [online], Israel business news - www.globes-online.com - on January 21, 2014

© Copyright of Globes Publisher Itonut (1983) Ltd. 2014

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018